(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 16.16% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Staar Surgical Co's revenue in 2025 is $230,591,000.On average, 12 Wall Street analysts forecast STAA's revenue for 2025 to be $12,990,111,026, with the lowest STAA revenue forecast at $12,071,377,154, and the highest STAA revenue forecast at $13,574,578,974. On average, 12 Wall Street analysts forecast STAA's revenue for 2026 to be $15,927,373,351, with the lowest STAA revenue forecast at $13,679,037,075, and the highest STAA revenue forecast at $17,993,156,659.
In 2027, STAA is forecast to generate $17,764,343,675 in revenue, with the lowest revenue forecast at $15,487,157,067 and the highest revenue forecast at $19,565,002,373.